STOCK TITAN

All For One Medi Financials

AFOM
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2023 Currency USD FYE September

This page shows All For One Medi (AFOM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AFOM FY2022

Tiny reported sales sit beside externally funded operating losses, making liquidity depend more on financing than on customers.

In FY2022, operating cash burn of -$497K was almost entirely offset by $501K of financing cash flow. That kept cash near $99K even as revenue was only $9K, a pattern that makes outside financing, not sales, the near-term source of day-to-day liquidity.

The move from an operating margin of -176.7% in FY2018 to -58.4% in FY2022 shows losses became less severe relative to sales. But revenue was only $9K while operating loss remained -$525K, so the improvement looks more like cost trimming than a business reaching workable scale.

The balance sheet is liability-heavy: FY2022 assets of $105K sat against liabilities of $15.4M, leaving negative equity and almost no asset cushion beneath the capital structure. Shares outstanding also expanded from 55.6M to 8.0B between FY2018 and FY2022, which suggests capital raising or restructuring has been a recurring operating support rather than growth capital building the asset base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating All For One Medi's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress
-534.91

All For One Medi scores -534.91, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($324) relative to total liabilities ($15.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$9K
YoY-5.3%

All For One Medi generated $9K in revenue in fiscal year 2022. This represents a decrease of 5.3% from the prior year.

EBITDA
N/A
Net Income
N/A
EPS (Diluted)
$0.00

All For One Medi earned $0.00 per diluted share (EPS) in fiscal year 2022.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$99K
YoY-2.8%
5Y CAGR-2.1%

All For One Medi held $99K in cash against $0 in long-term debt as of fiscal year 2022.

Dividends Per Share
N/A
Shares Outstanding
8.04B
YoY+91.8%

All For One Medi had 8.04B shares outstanding in fiscal year 2022. This represents an increase of 91.8% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
-5836.4%
YoY+583.6pp

All For One Medi's operating margin was -5836.4% in fiscal year 2022, reflecting core business profitability. This is up 583.6 percentage points from the prior year.

Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

AFOM Income Statement

Metric Q3'23 Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21
Revenue $3K+25.1% $2K-14.8% $2K+6.0% $2K-30.1% $3K+177.3% $1K-49.4% $2K-2.7% $2K
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $14K-4.2% $14K-62.3% $38K-7.0% $41K+47.9% $28K-65.9% $81K-12.5% $92K-35.7% $144K
Operating Income N/A -$69K N/A -$97K-19.2% -$82K+46.5% -$153K+21.0% -$193K+16.4% -$231K
Interest Expense N/A $175K N/A N/A N/A N/A $442K N/A
Income Tax N/A N/A N/A N/A N/A N/A $0 $0
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) $0.00 $0.00 $0.00 N/A $0.00 $0.00 $0.00 N/A

AFOM Balance Sheet

Metric Q3'23 Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21
Total Assets $8K-79.5% $37K+69.8% $22K-79.2% $105K+147.8% $43K-14.3% $50K-66.2% $147K+19.8% $123K
Current Assets $8K-79.5% $37K+69.8% $22K-79.2% $105K+190.5% $36K-26.9% $50K-66.2% $147K+19.8% $123K
Cash & Equivalents $2K-70.4% $6K-60.9% $15K-84.4% $99K+367.0% $21K-27.5% $29K-74.3% $114K+12.0% $101K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $15.7M+0.2% $15.6M+7.7% $14.5M-5.8% $15.4M+37.0% $11.3M-30.1% $16.1M+24.5% $12.9M-29.1% $18.2M
Current Liabilities $15.9M+0.2% $15.9M+7.5% $14.8M-5.7% $15.7M N/A N/A N/A $18.6M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$15.7M-0.3% -$15.6M-7.6% -$14.5M+5.3% -$15.3M-36.6% -$11.2M+30.1% -$16.1M-25.5% -$12.8M+29.4% -$18.1M
Retained Earnings -$26.2M-0.3% -$26.1M-4.5% -$24.9M+3.0% -$25.7M-21.7% -$21.1M+17.9% -$25.7M-15.7% -$22.2M+19.4% -$27.6M

AFOM Cash Flow Statement

Metric Q3'23 Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21
Operating Cash Flow -$10K+47.2% -$19K+76.7% -$83K+14.6% -$98K-84.7% -$53K+60.8% -$134K+36.5% -$212K+8.2% -$231K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A $0 N/A N/A N/A $0
Financing Cash Flow $6K-40.0% $10K $0-100.0% $175K+234.9% $52K+4.5% $50K-77.7% $224K-8.2% $244K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

AFOM Financial Ratios

Metric Q3'23 Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A -3363.3% N/A -4292.5%-1776.6pp -2516.0%+10531.4pp -13047.4%-4688.9pp -8358.5%+1366.7pp -9725.2%
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 0.000.0 0.000.0 0.000.0 0.01 N/A N/A N/A 0.01
Debt-to-Equity N/A N/A N/A N/A N/A N/A N/A N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$15.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

All For One Medi (AFOM) reported $9K in total revenue for fiscal year 2022. This represents a -5.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

All For One Medi (AFOM) revenue declined by 5.3% year-over-year, from $9K to $9K in fiscal year 2022.

All For One Medi (AFOM) reported diluted earnings per share of $0.00 for fiscal year 2022. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

All For One Medi (AFOM) had an operating margin of -5836.4% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.

All For One Medi (AFOM) generated -$497K in operating cash flow during fiscal year 2022, representing cash generated from core business activities.

All For One Medi (AFOM) had $105K in total assets as of fiscal year 2022, including both current and long-term assets.

All For One Medi (AFOM) had 8.04B shares outstanding as of fiscal year 2022.

All For One Medi (AFOM) had a current ratio of 0.01 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.

Based on fiscal year 2022 data, All For One Medi (AFOM) had $99K in cash against an annual operating cash burn of $497K. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

All For One Medi (AFOM) has negative shareholder equity of -$15.3M as of fiscal year 2022, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

All For One Medi (AFOM) has an Altman Z-Score of -534.91, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Back to top